The lung microenvironment: an important regulator of tumour growth and metastasis

Nasser K Altorki1,2,3, Geoffrey J Markowitz1,2, Dingcheng Gao1,2,3,4

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Nature Reviews. Cancer
|December 12, 2018
PubMed

Insights

Lung cancer, a leading cause of cancer deaths, involves complex tumor microenvironments. Understanding these environments offers new strategies for targeted lung cancer therapies and biomarkers.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Lung cancer is a leading global cause of cancer mortality.
  • Molecularly targeted therapies show promise but face resistance.
  • The tumor microenvironment's role in lung cancer is increasingly recognized.

Purpose of the Study:

  • To review recent advances in understanding the lung tumor microenvironment.
  • To explore how the microenvironment influences primary tumors and metastasis.
  • To discuss therapeutic and biomarker potential.

Main Methods:

  • Literature review of recent advances in lung cancer research.
  • Synthesis of concepts on tumor microenvironment reprogramming.
  • Analysis of inflammation, angiogenesis, and immune modulation.

Main Results:

  • The reprogrammed lung microenvironment promotes primary tumor growth and metastasis.
  • Key processes include inflammation, angiogenesis, and immune modulation.
  • Emerging concepts highlight the microenvironment's impact on therapy response.

Conclusions:

  • The lung tumor microenvironment is crucial for cancer progression and therapy resistance.
  • Targeting microenvironmental processes may overcome resistance.
  • Biomarkers and novel therapies can be developed from this understanding.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.8K